Ajooni Biotech Limited has informed the Exchange about change in Management
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajooni Biotech Limited has re-appointed Mr. Gursimran Singh (DIN: 02209675) as its Whole Time Director for a period of five years, from 14 August 2025 to 13 August 2030. The re-appointment was approved by shareholders through a special resolution at the company's 15th Annual General Meeting held on 29 September 2025. Mr. Gursimran Singh holds a B.Com and MBA, has over 15 years of experience in animal husbandry and agriculture, and has been serving as CEO of the company for the past 8 years. He is not related to any existing directors on the board and is not debarred by SEBI from holding a directorship.
This is a continuity move with no change in leadership — the existing CEO and WTD stays on for another five years, which brings stability but also means no fresh perspective at the top. Shareholders are unlikely to see a short-term stock reaction, as re-appointments of incumbent directors are generally viewed as routine corporate housekeeping.